SkinVision
by SkinVision
SkinVision's core product is a regulated AI-powered medical device (mobile app) that analyzes user-submitted photographs of moles and skin spots to assess skin cancer risk (melanoma, squamous cell carcinoma, basal cell carcinoma, actinic keratosis). The clinically validated algorithm provides a personalized health path recommendation, achieving published sensitivity of ~90%+ in detecting common skin cancers, developed in partnership with academic institutions including LMU Munich and Mayo Clinic.
Transparency Score
Weighted across four pillars · updated September 4, 2026
Capabilities
Vendor Information
Complete information about the vendor/provider of this AI application
EU AI Act Provider Information
Get insights into risk by running assessments on this AI application.
Work at SkinVision? Claim this listing to correct or complete the data.
Ready to manage AI applications?
Track, assess, and govern your AI applications with Anove.